ESR1 and breast cancer: A study involving the careful integration of molecular docking, X-ray crystallography and rational drug design was successful in the identification of potent and specific covalent 14-3-3/ERα small-molecule stabilizers.381 This approach holds considerable promise due to the direct link between ERα and breast cancer development and cell proliferation.